In one paragraphArticle in EBioMedicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
2 authors.
Daniel H DaneshvarDepartment of Physical Medicine and Rehabilitation, Harvard Medical School; Boston, MA; Department of Physical Medicine and Rehabilitation, Massachusetts General Hospital, Boston, MA; Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Boston, MA.
Michael L AloscoBoston University Alzheimer's Disease Research Center and Boston University CTE Center, Boston University School of Medicine, Boston, MA; Department of Neurology, Boston University School of Medicine, Boston, MA. Electronic address: malosco@bu.edu.
Funding
RL5: Research Education CoreP30AG072978 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Lindsay A. Farrer · 2021 to 2026
$25.6MTraumatic Brain Injury and Repetitive Head Impacts: Contributions to AD/ADRD and CTE Neuropathology and Resulting Clinical SyndromesU54NS115266 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MCKEE, ANN C. · 2019 to 2023
$10.3MTraining Program in Recovery and Restoration of CNS health and functionT32NS100663 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI LEIGH R HOCHBERG, JONATHAN ROSAND · 2017 to 2026
$2.5MLate Pathologies of Exposure to Repetitive Head Impacts from Contact Sports: White Matter and Vascular Contributions to Cognitive Impairment, Dementia, and Neuropsychiatric SymptomsRF1NS122854 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ALOSCO, MICHAEL, MCKEE, ANN C. · 2021 to 2021
$2.3MRepetitive Head Impact Exposure and Later-Life White Matter Signal Abnormalities: An Investigation in Former NFL Players, Subjects with Alzheimer's Disease, and Cognitively Normal ControlsK23NS102399 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ALOSCO, MICHAEL · 2018 to 2022
$793kIn Vivo Detection of Chronic Traumatic Encephalopathy with 18F-MK-6240 Tau PETR21NS120629 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ALOSCO, MICHAEL, RABINOVICI, GIL DAN · 2021 to 2022
$461kNIA NIH HHS P30 AG072978NINDS NIH HHS K23 NS102399NINDS NIH HHS R21 NS120629NINDS NIH HHS RF1 NS122854NINDS NIH HHS T32 NS100663NINDS NIH HHS U54 NS115266
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Brain Injuries, TraumaticBiomarkersCost-Benefit AnalysisHumansBiomarkers
Identifiers
PMID35074628
PMCPMC8792432
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390